BAAPS audit shows 8% drop in breast enlargements

Breast augmentations fell 8% in the British Association of Aesthetic Plastic Surgeons’ 2025 audit, while implant removals rose 6%, shifting attention to how patients weigh volume, shape and long-term follow-up. Istanbul surgeon Dr Aykut Özpür says the numbers underscore the need to match the operation to the actual concern, not the trend.

Why it matters: - The BAAPS audit points to changing priorities in breast surgery, with fewer enlargements and more implant removals. - The shift matters because breast augmentation, uplift, reduction and explant surgery can solve different problems. - For patients, the question is increasingly whether they want more volume, a different shape or less volume.

What happened: - The British Association of Aesthetic Plastic Surgeons reported 2025 activity in a release published April 15, 2026. - Breast augmentation fell 8% to 4,761 procedures. - Breast reduction came close behind at 4,673 procedures. - Implant removals rose 6% to 850. - Dr Aykut Özpür, a plastic surgeon in Istanbul, is using the figures to discuss how patients should think about breast volume, shape and procedure choice.

The details: - Özpür says a consultation should separate different goals, such as more fullness, a higher breast position or less volume. - Özpür says the right operation depends on which concern matters most and which procedure can realistically address it. - Özpür warns that choosing a procedure because it is fashionable can leave the main concern unresolved. - His breast uplift information says the operation reshapes tissue and removes excess skin, and may include an implant if existing volume is not enough. - That means a breast uplift and a breast enlargement can answer different parts of a patient’s request. - The BAAPS audit captures activity recorded by the association and should not be read as a count of every UK patient having surgery at home or abroad. - Augmentation remained BAAPS’s most frequently recorded cosmetic procedure, despite the decline.

Between the lines: - The audit does not show why any individual chose surgery. - The figures do not prove breast enlargement is becoming obsolete. - The change in the procedure mix suggests surgeons may need to spend more time clarifying whether a patient wants volume, position or both. - NHS guidance says breast implants are not lifetime devices and may need replacement. - NHS advice also stresses discussing implant type, positioning and follow-up with the surgeon. - Those issues matter for both first-time augmentations and revision decisions. - NHS guidance on treatment abroad says patients should confirm where follow-up will happen and what support exists if complications or further surgery are needed. - That point is especially relevant for UK patients considering surgery in Turkey.

What's next: - Özpür says consultations should focus on concrete questions about what each procedure would change and what ongoing care would involve. - Patients considering implant removal may also need to discuss whether an uplift or another approach is appropriate. - The next step for any patient is to match the treatment plan to the body, the expected result and the recovery plan.

The bottom line: - The BAAPS figures do not signal one universal answer for breast surgery. - They show why the best procedure depends on the patient’s real goal, not the trend line.